Dr. Shah is a pharmaceutical consultant. He was Scientific Secretary (2003 – 2011) of International Pharmaceutical Federation (FIP) and Chair of Regulatory Sciences Special Interest Group of FIP (2011-2016). He is a Steering Committee Member (2009 – present) of Non-Biological Complex Drugs housed at Lygature, The Netherlands. Dr. Shah retired from US FDA (Food and Drug Administration) as a Senior Research Scientist after 30 years of service in July 2005. At FDA, he developed several Regulatory Guidances for Pharmaceutical Industry in the area of bioanalytical methods validation, dissolution, SUPAC, bioequivalence and biopharmaceutics. He has received several FDA Awards including Award of Merit, Scientific Achievement Award and Distinguished Career Service Award. Dr. Shah is author/co-author of over 300 scientific papers and is a co-editor of four books. Dr. Shah was the President of American Association of Pharmaceutical Scientist (AAPS) in 2003. He is a Fellow of AAPS and FIP. Dr. Shah is a recipient of FIP Lifetime Achievement Award in Pharmaceutical Sciences, Honorary Doctorate from Semmelweis University, Hungary and from University of Medicine and Pharmacy Carol Davila Bucharest, Romania.